243 related articles for article (PubMed ID: 31319341)
1. Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.
Gopaldas M; Zanderigo F; Zhan S; Ogden RT; Miller JM; Rubin-Falcone H; Cooper TB; Oquendo MA; Sullivan G; Mann JJ; Sublette ME
J Affect Disord; 2019 Oct; 257():495-503. PubMed ID: 31319341
[TBL] [Abstract][Full Text] [Related]
2. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.
Miller JM; Everett BA; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
Synapse; 2016 Jan; 70(1):24-32. PubMed ID: 26426356
[TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter binding in major depressive disorder: impact of serotonin system anatomy.
Bartlett EA; Zanderigo F; Shieh D; Miller J; Hurley P; Rubin-Falcone H; Oquendo MA; Sublette ME; Ogden RT; Mann JJ
Mol Psychiatry; 2022 Aug; 27(8):3417-3424. PubMed ID: 35487966
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
[TBL] [Abstract][Full Text] [Related]
6. Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder.
Beier AM; Lauritzen L; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
J Psychiatr Res; 2014 Oct; 57():133-40. PubMed ID: 25017608
[TBL] [Abstract][Full Text] [Related]
7. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
[TBL] [Abstract][Full Text] [Related]
8. In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior.
Bartlett EA; Zanderigo F; Stanley B; Choo TH; Galfalvy HC; Pantazatos SP; Sublette ME; Miller JM; Oquendo MA; Mann JJ
Eur Neuropsychopharmacol; 2023 May; 70():1-13. PubMed ID: 36780841
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740
[TBL] [Abstract][Full Text] [Related]
10. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
[TBL] [Abstract][Full Text] [Related]
11. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
Schneck N; Miller JM; Delorenzo C; Kikuchi T; Sublette ME; Oquendo MA; Mann JJ; Parsey RV
J Affect Disord; 2016 Jan; 190():494-498. PubMed ID: 26561939
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acids as predictors of future suicide attempt.
Daray FM; Grendas LN; Rodante DE; Errasti AE; Cases GG; Moix CF; Uicich RE; GimÉnez MI; Puppo S; Fasolino GH; Portela A; Galfalvy HC; Sublette ME
Prostaglandins Leukot Essent Fatty Acids; 2021 Feb; 165():102247. PubMed ID: 33482466
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression.
Chhetry BT; Hezghia A; Miller JM; Lee S; Rubin-Falcone H; Cooper TB; Oquendo MA; Mann JJ; Sublette ME
J Psychiatr Res; 2016 Apr; 75():65-74. PubMed ID: 26802812
[TBL] [Abstract][Full Text] [Related]
15. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder.
McNamara RK; Jandacek R; Rider T; Tso P; Dwivedi Y; Pandey GN
J Affect Disord; 2010 Oct; 126(1-2):303-11. PubMed ID: 20413162
[TBL] [Abstract][Full Text] [Related]
16. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
[TBL] [Abstract][Full Text] [Related]
17. A hybrid deconvolution approach for estimation of in vivo non-displaceable binding for brain PET targets without a reference region.
Zanderigo F; Mann JJ; Ogden RT
PLoS One; 2017; 12(5):e0176636. PubMed ID: 28459878
[TBL] [Abstract][Full Text] [Related]
18. Quantifying serotonin transporters by PET with [11C]-DASB before and after interferon-α treatment.
Shapiro PA; Sloan RP; Deochand C; Franceschi AM; Delorenzo C; Mann JJ; Parsey RV
Synapse; 2014 Nov; 68(11):548-55. PubMed ID: 25043294
[TBL] [Abstract][Full Text] [Related]
19. A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
Iscan Z; Rakesh G; Rossano S; Yang J; Zhang M; Miller J; Sullivan GM; Sharma P; McClure M; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
Eur Neuropsychopharmacol; 2017 Oct; 27(10):1011-1021. PubMed ID: 28811068
[TBL] [Abstract][Full Text] [Related]
20. Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.
Selvaraj S; Murthy NV; Bhagwagar Z; Bose SK; Hinz R; Grasby PM; Cowen PJ
Psychopharmacology (Berl); 2011 Feb; 213(2-3):555-62. PubMed ID: 19756523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
